Skip to content

Net Income at other companies

Schrodinger logo
SchrodingerSDGR
-$60.03M-0.4%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
-$117.5M+42.0%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
-$69.01M-54.1%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$43.17M+5.4%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$52.88M-34.5%
ADMA Biologics logo
ADMA BiologicsADMA
$45.33M+68.5%

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's net income?
Absci Corporation (ABSI) reported net income of -$29.6M in Q1 2026.
How has Absci Corporation's net income changed year-over-year?
Absci Corporation's net income decreased by 12.3% year-over-year, from -$26.35M to -$29.6M.
What is the long-term trend for Absci Corporation's net income?
Over 4 years (2021 to 2025), Absci Corporation's net income has grown at a 3.3% compound annual growth rate (CAGR), from -$100.96M to -$115.18M.
What does net income mean?
Net income as the starting point for the indirect method operating cash flow reconciliation.